Shareholding disclosure

Amgen Inc

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

14.05.2015

Transaction

11.05.2015

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAF5D00018

Beneficial owner

Amgen Inc

Declared address

Amgen Inc., 19808 Wilmington

Bond conversion into equity. The restructuring of the convertible bonds announced by the Company has been effected. The percentage indicated below is based on the increased share capital of the Company (as per the entry in the commercial register). Warrants are directly held by Amgen Investments Ltd.,Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda, which is owned 100% by Amgen Manufacturing Ltd.,Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda. Amgen Manufacturing Ltd. is owned 100% by Amgen Technology Ltd., Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda, which is owned 10% by Amgen International LLC, 2711 Centerville Road, Suite 400 Wilmington, DE 19808, USA, and 90% by Amgen Inc., 2711 Centerville Road, Wilmington, DE 19808, USA, a public company listed on the NASDAQ. Amgen Inc. owns 100% of Amgen International LLC.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open